These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 36293225)

  • 1. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.
    Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease.
    Zaiou M
    World J Gastroenterol; 2022 Sep; 28(35):5111-5128. PubMed ID: 36188722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers.
    Khalifa O; Errafii K; Al-Akl NS; Arredouani A
    Dis Markers; 2020; 2020():8822859. PubMed ID: 33133304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD).
    Tao Q; Xie J; Wu Y; Jin Y
    Gastroenterol Hepatol; 2024 May; 47(5):506-516. PubMed ID: 37806343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review.
    Shi N; Sun K; Tang H; Mao J
    J Clin Lab Anal; 2023 Jun; 37(11-12):e24943. PubMed ID: 37435630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.
    Gori M; Arciello M; Balsano C
    Biomed Res Int; 2014; 2014():741465. PubMed ID: 24745023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
    Cui J; Wang Y; Xue H
    Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs.
    Mukherjee AG; Wanjari UR; Gopalakrishnan AV; Katturajan R; Kannampuzha S; Murali R; Namachivayam A; Ganesan R; Renu K; Dey A; Vellingiri B; Prince SE
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Zhang C; Wang P; Li Y; Huang C; Ni W; Chen Y; Shi J; Chen G; Hu X; Ye M; Duan S; Wang K
    Anat Rec (Hoboken); 2019 Feb; 302(2):193-200. PubMed ID: 30312023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism.
    Qiu W; Zhang S; Yu W; Liu J; Wu H
    Comput Biol Med; 2024 Sep; 180():108867. PubMed ID: 39089114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.
    Khashkhashi Moghadam S; Bakhshinejad B; Khalafizadeh A; Mahmud Hussen B; Babashah S
    J Cell Mol Med; 2022 Jan; 26(2):287-305. PubMed ID: 34907642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
    Lv H; Lv G; Han Q; Yang W; Wang H
    Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
    El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
    J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A micro-RNA expression signature for human NAFLD progression.
    Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
    J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
    Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
    PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Analysis of mRNA-lncRNA-miRNA Interactions in Hepatocellular Carcinoma.
    Tang X; Feng D; Li M; Zhou J; Li X; Zhao D; Hao B; Li D; Ding K
    Sci Rep; 2019 Nov; 9(1):16096. PubMed ID: 31695090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.